MIAMI -- Marvin A Sackner, M.D., Chief Executive Officer of Non-Invasive Monitoring Systems, Inc. [NIMS] (OTCBB:NIMU) announced that the FDA has granted approval to NIMS to market Exer-Rest as a Class I (exempt) therapeutic vibrator with the following intended uses: "as an aid to temporarily increase local circulation, to provide temporary relief of minor aches and pains, and local muscle relaxation." Exer-Rest has the configuration of a single or twin bed and is fitted with a memory foam mattress. This medical device produces Whole Body Periodic Acceleration [vibration] (WBPA) to an individual (who lies horizontally on the mattress) through repetitive head-foot movements at approximately 140 times per minute during a 30 to 45 minute session. The movements are obtained by a patented motorized platform which is adjustable for speed, distance and time through a wireless digital controller. Non-invasive, drug-free WBPA treatments are usually administered daily five to seven days a week for symptomatic relief. WBPA technology is protected by four US patents.
1. Head Entrapment under Bunk Bed Guard Rails.2. Falling Mattresses or Foundations Can Cause Injury or Even Kill A Small Child.6. Metal Bunk Beds
Safe Harbor Statement: Under the Private Securities Litigation Reform Act of 1995: The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
No comments:
Post a Comment